Evidence map›Paper›PMID 32280814›Full record

ReviewAdvances in radiation oncology

Measure Twice: Promise of Liquid Biopsy in Pediatric High-Grade Gliomas.

Matthew S Dietz, Catherine Z Beach, Ramon Barajas, Michael S Parappilly, Sidharth K Sengupta, Lissa C Baird, Jeremy N Ciporen, Seunggu J Han, Rebecca Loret de Mola, Yoon Jae Cho and 4 more

Open access · goldAbstract readReview
In one paragraph

Review in Advances in radiation oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Matthew S DietzDepartment of Pediatrics, Oregon Health & Science University, Portland, Oregon.
Catherine Z BeachDepartment of Radiation Medicine, Oregon Health & Science University, Portland, Oregon.
Ramon BarajasDepartment of Diagnostic Radiology, Oregon Health & Science University, Portland, Oregon.
Michael S ParappillyDepartment of Diagnostic Radiology, Oregon Health & Science University, Portland, Oregon.
Sidharth K SenguptaDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon.
Lissa C BairdDepartment of Neurological Surgery, Oregon Health & Science University, Portland, Oregon.
Jeremy N CiporenDepartment of Neurological Surgery, Oregon Health & Science University, Portland, Oregon.
Seunggu J HanDepartment of Neurological Surgery, Oregon Health & Science University, Portland, Oregon.
Rebecca Loret de MolaDepartment of Pediatrics, Oregon Health & Science University, Portland, Oregon.
Yoon Jae ChoDepartment of Neurology, Oregon Health & Science University, Portland, Oregon.
Kellie J NazemiDepartment of Pediatrics, Oregon Health & Science University, Portland, Oregon.
Shearwood McClellandDepartment of Radiation Oncology, Indiana University School of Medicine, Indianapolis, Indiana.
Melissa H WongDepartment of Cell, Developmental & Cancer Biology, Oregon Health & Science University, Portland, Oregon.
Jerry J JaboinDepartment of Radiation Medicine, Oregon Health & Science University, Portland, Oregon.
Oregon Health & Science University · USIndiana University School of Medicine

Funding

Understanding the origins of rapid recurrence of pancreatic cancer after resectionP30CA069533 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Grace B Gill · 1997 to 2026
$60.5M
Oregon Clinical and Translational Research Institute TL1 ProgramTL1TR002371 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI ALLISON Deborah FRYER, JESSINA C MCGREGOR · 2017 to 2026
$6.2M
Novel mechanisms of cancer metastasisR21CA172334 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI WONG, MELISSA H. · 2013 to 2014
$363k
NCATS NIH HHS TL1 TR002371NCI NIH HHS P30 CA069533NCI NIH HHS R21 CA172334
6 · The paper itself

Abstract

purposeTo review and critique the current state of liquid biopsy in pHGG. MATERIALS AND

methodsPublished literature was reviewed for articles related to liquid biopsy in pediatric glioma and adult glioma with a focus on high-grade gliomas.

resultsThis review discusses the current state of liquid biomarkers of pHGG and their potential applications for liquid biopsy development.

conclusionsWhile nascent, the progress toward identifying circulating analytes of pHGG primes the field of neuro-oncoogy for liquid biopsy development.

Identifiers

PMID32280814
PMCPMC7136635
OpenAlexW3003213316

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.